Ten years of German benefit assessment: price analysis for drugs with unproven additional benefit mydrg.de

library_books

Ten years of German benefit assessment: price analysis for drugs with unproven additional benefit

• B.S.
• Montag, 14.08.2023

Ten years of German benefit assessment: price analysis for drugs with unproven additional benefit (Cambridge University Press).

Arzneimittel - Arzneimittelmarktneuordnungsgesetz (AMNOG) - G-AEP - Gemeinsamer Bundesausschuss - Medikamente - Nutzenbewertung - URL

« IAT-Studie zur Fachkräftesicherung in der Pflege | Ten years of German benefit assessment: price analysis for drugs with unproven additional benefit | Weiterer Chefarzt verlässt das Städtische Krankenhaus Eisenhüttenstadt »